Sagimet Biosciences Inc
SGMT8.450USD
+0.200+2.42%
Close 08/04, 16:00（ET）Quotes delayed by 15 min
8.450USD+8.450After-hours (ET)
272.05MMarket Cap
LossP/E TTM
Sagimet Biosciences Inc
8.450
+0.200+2.42%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q2
FY2022Q1
FY2021Q1
Total revenue
----
--0.00
-100.00%0.00
----
----
--0.00
--2.00M
----
----
----
----
----
Revenue
----
--0.00
-100.00%0.00
----
----
--0.00
--2.00M
----
----
----
----
----
Operating expenses
126.56%19.86M
92.21%18.20M
78.82%16.90M
50.05%10.59M
29.61%8.77M
--9.47M
--9.45M
-2.50%7.06M
-22.62%6.76M
--7.24M
82.03%8.74M
--4.80M
R&D expenses
191.56%15.34M
151.34%14.22M
155.20%12.65M
35.01%6.31M
17.27%5.26M
--5.66M
--4.96M
-26.60%4.68M
-23.47%4.49M
--6.37M
74.81%5.86M
--3.35M
Depreciation, depletion, and amortization
--0.00
----
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
----
----
Operating profit
-126.56%-19.86M
-92.21%-18.20M
-126.81%-16.90M
-50.05%-10.59M
-29.61%-8.77M
---9.47M
---7.45M
2.50%-7.06M
22.62%-6.76M
---7.24M
-82.03%-8.74M
---4.80M
Net non-operating interest income (expenses)
Non-operating interest income
-21.04%1.69M
51.75%1.99M
108.49%2.28M
811.81%2.47M
1088.33%2.14M
--1.31M
--1.09M
99.26%271.00K
2900.00%180.00K
--136.00K
0.00%6.00K
--6.00K
Special income (expenses)
----
----
-100.00%0.00
----
100.00%0.00
--1.00K
--4.00K
--1.00K
-200.00%-2.00K
--0.00
100.27%2.00K
---751.00K
Income before tax
-174.19%-18.18M
-98.76%-16.20M
-130.11%-14.62M
-19.65%-8.12M
-0.64%-6.63M
---8.15M
---6.35M
4.46%-6.79M
24.59%-6.59M
---7.10M
-57.44%-8.73M
---5.55M
Income after tax
-174.19%-18.18M
-98.76%-16.20M
-130.11%-14.62M
-19.65%-8.12M
-0.64%-6.63M
---8.15M
---6.35M
4.46%-6.79M
24.59%-6.59M
---7.10M
-57.44%-8.73M
---5.55M
Net income from continuous operations
-174.19%-18.18M
-98.76%-16.20M
-130.11%-14.62M
-19.65%-8.12M
-0.64%-6.63M
---8.15M
---6.35M
4.46%-6.79M
24.59%-6.59M
---7.10M
-57.44%-8.73M
---5.55M
Net income attributable to controlling interests
-174.19%-18.18M
-98.76%-16.20M
-130.11%-14.62M
-19.65%-8.12M
-0.64%-6.63M
---8.15M
---6.35M
4.46%-6.79M
24.59%-6.59M
---7.10M
-57.44%-8.73M
---5.55M
Net income attributable to common shareholders
-174.19%-18.18M
-98.76%-16.20M
-130.11%-14.62M
-19.65%-8.12M
-0.64%-6.63M
---8.15M
---6.35M
4.46%-6.79M
24.59%-6.59M
---7.10M
-57.44%-8.73M
---5.55M
Basic earnings per share
-147.31%-0.56
-44.31%-0.50
-30.25%-0.45
16.87%-0.25
25.32%-0.23
---0.35
---0.35
7.15%-0.31
24.59%-0.31
---0.33
-57.44%-0.41
---0.26
Diluted earnings per share
-147.31%-0.56
-44.31%-0.50
-30.25%-0.45
16.87%-0.25
25.32%-0.23
---0.35
---0.35
7.15%-0.31
24.59%-0.31
---0.33
-57.44%-0.41
---0.26
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
